Even so, TIMP-1-expressing cells are more resistant to chemotherapy than are TIMP-1 gene-deficient, and in CRC patients, high levels of TIMP-1 in tumor tissue and plasma are strongly associated with shorter survival time [86]. Here, TIMP1 is linked to colorectal carcinoma.